← Back to all trials
Recruiting
NCT07215884
Dopamine and Sensorimotor Function in Stuttering
Conditions: Stuttering, Adult
Sex: All
Ages: 18 Years – 65 Years
Healthy volunteers: Yes
Phase: PHASE1
Enrollment: 25
Sponsor: University of California, San Francisco
Location: Biomagentic Imaging Lab San Francisco California
Summary
This study is being done to understand the effect of aripiprazole on adults who stutter. Stuttering is a disorder that affects speech fluency. This study aims to understand sensorimotor pathways of stuttering and possible interventions.
Eligibility Criteria
Inclusion Criteria:
* native speakers of American English
* for adults who stutter, presence of stuttering will be confirmed, with onset before age 6 years
* Normal hearing
* Ages of 18 to 65 years
* healthy adults without hearing-language difficulties
Exclusion Criteria:
* self-reported speech-language-hearing difficulties other than stuttering
* self-reported neurological or psychological problems
* other medications (drugs that affect dopaminergic system and/or benzodiazepines)
Source: ClinicalTrials.gov (NCT07215884). StuddyBuddy aggregates publicly available trial information.